The largest database of trusted experimental protocols

95 protocols using cyclopamine

1

Modulating Sonic Hedgehog and EAAT2 in Traumatic Brain Injury

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sonic hedgehog and EAAT2 modulation was performed as illustrated in Figure 1.
Purmorphamine: Undamaged fish were intraperitoneally (IP) injected with ~40 µL of 10 µM Purmorphamine (Sigma-Aldrich, St. Louis, MO, USA) using a 30 gauge needle every 12 h for 48 h (0, 12, 24, 36, and 48 h).
Cyclopamine: Fish were exposed to sTBI and IP injected with ~40 µL of 2 mM Cyclopamine (Sigma-Aldrich, St. Louis, MO, USA) using a 30 gauge needle at 4, 12, 24, 36, and 48 hpi.
ceftriaxone: Undamaged fish were IP injected with ~40 µL of 10 mM ceftriaxone (Sigma-Aldrich, St. Louis, MO, USA) using a 30 gauge needle ever 12 h for 48 h (0, 12, 24, 36, and 48 h).
6-Cyano-7-nitroquinoxaline-2,3-dione (CNQX): Fish were exposed to sTBI and IP injected with ~40 µL of 2 mM CNQX (Sigma-Aldrich, St. Louis, MO, USA) and 2 mM Cyclopamine using a 30 gauge needle at 4, 12, 24, 36, and 48 hpi.
Valproic acid (VPA): Fish were exposed to sTBI and IP injected with ~40 µL of 2 mM VPA (Sigma-Aldrich, St. Louis, MO, USA) and 2 mM Cyclopamine using a 30 gauge needle at 4, 12, 24, 36, and 48 hpi.
GABAPentin (GABAP): Fish were exposed to sTBI and IP injected with ~40 µL of 3 mM GABAP (Sigma-Aldrich, St. Louis, MO, USA) and 2 mM Cyclopamine using a 30 gauge needle at 4, 12, 24, 36, and 48 hpi.
+ Open protocol
+ Expand
2

Osteogenic Differentiation of MSCs with Naproxen

Check if the same lab product or an alternative is used in the 5 most similar protocols
In every well of a six-well plate (Sarstedt, QC, Canada), 5 × 105 MSCs were plated and cultured in expansion medium overnight. The floating cells were removed and the attached cells were cultured until the confluence was more than 90%. Then the cells were cultured in osteogenic differentiation medium for 3 days to allow the cells to adapt to the new environment. Afterwards, the cells were cultured in 3 mL/well of osteogenic differentiation medium with 0.5 μM Npx (Sigma-Aldrich, Oakville, ON, Canada). The cells cultured without Npx were used as control cells. To test the effect of cyclopamine (Cpn) on gene expression in MSCs, 0.5 μM cyclopamine (Sigma-Aldrich) was dissolved in the culture medium. The osteogenic differentiation medium was prepared with high-glucose DMEM containing 10% FBS, 0.1 μM dexamethasone, 10 mM β-glycerophosphate, 50 μM L-ascorbic acid, 100 units/mL penicillin, and 100 μg/mL streptomycin.
+ Open protocol
+ Expand
3

Smoothened Inhibition in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sca1-eGFP mice were treated with the Smoothened inhibitor, cyclopamine,
or the vehicle 2-hydropropyl-β-cyclodextrin (HβCD)
(Sigma-Aldrich) alone as a control, (essentially as described by van den Brink
(van den Brink et al. 2001 (link))). Mice
were injected (250 μl max volume) intraperitoneally (IP) 1 day before
ligation, then every other day after ligation at a dose of 10 mg/kg cyclopamine
(Sigma-Aldrich) dissolved in a solution of 45% (w/v) HβCD. There
was no effect of cyclopamine treatment on mouse body weight, compared to the
HβCD vehicle control group (data not shown).
+ Open protocol
+ Expand
4

Smoothened Inhibitor Treatment in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sca1-eGFP mice were treated with the smoothened inhibitor, cyclopamine, or the vehicle 2-hydropropyl-β-cyclodextrin (HβCD) (Sigma–Aldrich) alone as a control, (essentially as described previously)86 (link). Mice were injected (250 μl max volume) intraperitoneally (IP) 1 day before ligation, then every other day after ligation at a dose of 10 mg/kg cyclopamine (Sigma–Aldrich) dissolved in a solution of 45% (w/v) HβCD. There was no effect of cyclopamine treatment on mouse body weight, compared to the HβCD vehicle control group (data not shown).
+ Open protocol
+ Expand
5

Spinal Cord Injury Modeling in Zebrafish

Check if the same lab product or an alternative is used in the 5 most similar protocols
The protocol to perform spinal cord injury in zebrafish larvae was previously described [38 ]. Transgenic larvae (Tg(0.6foxj1a:GFP)) at 5 dpf were anaesthetized in 0.016% tricaine in embryo medium and placed on their side in a drop of medium in a Petri dish. The injury was performed at the level of the anal pore using a 20G × 1″ syringe needle (Terumo) to transect the region dorsal to the notochord that contains the spinal cord. Injured larvae were carefully transferred to fresh embryo medium and maintained at 28°C until the time of analysis.
To inhibit the Shh signalling pathway in injured larvae, cyclopamine (Sigma, C4116) was added at a concentration of 200 µM to the medium 1 day after the injury and fresh medium with cyclopamine was added again at 2 dpi. A control group of injured larvae was treated with an equivalent volume of DMSO (cyclopamine vehicle). The drug-treated larvae were kept in the dark at 28°C until the time of analysis.
+ Open protocol
+ Expand
6

Modulation of Embryonic Development

Check if the same lab product or an alternative is used in the 5 most similar protocols
Embryos were incubated in embryo media with DMSO or: 12.5 µM or 25 µM of MG132 (Sigma-Aldrich) in DMSO, 10 µM AGN 194310 (Med Chem Express) in DMSO, 0.2 µM DMH1 (Sigma-Aldrich) in DMSO, 10 µM cyclopamine (Sigma-Aldrich) in EtOH or 75 µM purmorphamine (Sigma-Aldrich) in DMSO starting at 5.5 hpf for cyclopamine and purmorphomine and 10 hpf for AGN194310, DMH1 and MG132, all embryos were fixed at 24 hpf.
+ Open protocol
+ Expand
7

Developing Zebrafish Embryo Drug Delivery

Check if the same lab product or an alternative is used in the 5 most similar protocols
All the drugs were directly delivered in egg water of dechorionated embryos with the exception of αBungarotoxin as specified below. Mitochondria-targeting drugs (Figure 8 and Supplementary Figure S8) were added from 24 hpf and rinsed at 28 hpf or at 48 hpf, with the following concentrations: FCCP (C2920, Sigma-Aldrich, 100 nM, 500 nM, 1 μM); Oligomycin A (75351, Sigma-Aldrich, 3 μM); Valinomycin (V1644, Invitrogen, 1 μM); Rotenone (R8875, Sigma-Adrich, 100 nM); H2O2 (31642, Sigma-Aldrich, 100 μM, 2 mM); MDIVI-1 (M0199, Sigma-Aldrich, 50 μM); Paraquat (36541, Sigma-Aldrich, 100 μM) and Na2SO3 (S0505, Sigma-Aldrich, 150 mM). Morphogens-targeting drugs (Figure 7) were applied from 10 hpf: Shh-antagonist Cyclopamine (C4116, Sigma-Aldrich, 50 μM); Shh-agonist SAG (sml1314; Sigma-Aldrich, 10 μM), BMP-antagonist DMH1 (D8946, Sigma-Aldrich, 10 μM). To block muscle contractions, 4 nl of αBungarotoxin-TRITC (T0195, Sigma-Aldrich, 100 μM) were injected in the blood stream of 24 hpf embryos.
+ Open protocol
+ Expand
8

iPSK3 Cell Differentiation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Undifferentiated human iPSK3 cells were seeded into ultra-low attachment (ULA) 24-well plates (Corning Inc., Corning, NY) at 3 × 105 cells/well in differentiation medium composed of DMEM/F-12 plus 2% B27 serum-free supplement (Life Technologies, Carlsbad, CA). iPSK3 cells were seeded in the presence of Y27632 (10 μM). After 24 h, Y27632 was removed and the formed embryoid bodies (EB) were treated with dual SMAD signaling inhibitors of 10 μM SB431542 (Sigma-Aldrich, St. Louis, MO) and 100 nM LDN193189 (Sigma) over 7 days. Then on day 8, the spheroids were treated with fibroblast growth factor (FGF)-2 (10 ng/mL, Life Technologies) and cyclopamine (an Shh inhibitor, 1 μM, Sigma) for cortical differentiation for 21 days.22 (link),33 (link),34 (link) The cells were replated onto growth factor reduced Matrigel-coated surfaces and treated with different iron oxide nanoparticles for another 2–4 days prior to further downstream experiments (Figure 1B, C). On the basis of our previous studies,35 (link),36 (link) the labeling efficiency for microsized particles of iron oxides (MPIO) can reach 50–80%. It was estimated that the labeling efficiency for nanoscale iron oxides should be similar or higher than MPIO.
+ Open protocol
+ Expand
9

Embryonic Limb Bud Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cyclopamine (Sigma) was suspended in control carrier (45% 2-hydropropyl-β-cyclodextrin in PBS, Sigma, to a concentration of 1 μg/μl) and 4 μl pipetted directly onto embryos over the limb bud, after removal of vitelline membranes. PD0332991 was resuspended in DMEM at a concentration of and 0.1 μg/μl and 20 μl pipetted after removal of vitelline membranes. Note in all cases, control wings were treated with 2-hydropropyl-β-cyclodextrin (HBC) or DMEM only.
+ Open protocol
+ Expand
10

Cyclopamine Treatment of Limb Buds

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cyclopamine (Sigma) was suspended in control carrier [45% 2-hydropropyl-β-cyclodextrin in PBS (Sigma)] to a concentration of 1 mg/ml and 4 μl was pipetted directly onto embryos over the limb bud, after removal of vitelline membranes. Note that in all cases, untreated wings were treated with 2-hydropropyl-β-cyclodextrin only.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!